System Biosciences

Palo Alto, United States Founded: 2009 • Age: 17 yrs
Reagents and technologies for genomics and proteomics research are provided.

About System Biosciences

System Biosciences is a company based in Palo Alto (United States) founded in 2009. System Biosciences operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.

  • Headquarter Palo Alto, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website systembio.com
  • Social LinkedIn X Facebook
  • Legal Name Asbi Production Cz S.R.O.
Key Metrics
  • Latest Funding Round
    $156.96K (USD), Grant

    Aug 2016

  • Investors
    HHS

    & 1 more

Funding Insights of System Biosciences

  • Total Rounds 12
  • Last Round Grant β€” $156,962
  • First Round $972,828

    (Apr 2008)

  • Investors Count 2

Latest 10 of 12 funding rounds of System Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2016$156,962Grant––
Jul 2012$105,000Grant––
Jun 2012$102,480Grant––
Mar 2011$105,000Grant––
Aug 2009$149,090Grant––
May 2009$972,828Grant––
Apr 2009$180,703Grant––
Mar 2009$180,703Grant––
Jan 2009$172,376Grant––
Jan 2009$172,376Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in System Biosciences

System Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Military Health.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Administers health care and support for military personnel and operations.
–health.milFalls Church, United States
Premium access

Investor details for System Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of System Biosciences

3 people are tracked at System Biosciences (2 in leadership, 1 in team).

NameRoleGroup
Fangting Wu
Associate Director of R&DLeadership
Vinh Q. Lam, PhD
Associate Director of MarketingLeadership
Laurie Goldman
Sales managerTeam
Premium access

Complete people profiles for System Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of System Biosciences

3 dated milestones of System Biosciences across 8 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $973K.
  2. Founded System Biosciences is founded.
  3. Funding Latest funding round, Grant, of $157K.

Competitors of System Biosciences

System Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
helix.com2015San Francisco, United States$435M–
Genomic database for clinical research is provided.
benchling.com2012San Francisco, United States$411.9M640
Cloud-based bioinformatics platform is offered for biotech research.
genuitysci.com2013Boston, United States$515M–
AI-based omics data analysis solutions are provided to researchers.
inpharmatica.co.uk1998London, United Kingdom–62
Developer of predictive informatics based platform for drug discovery
bioagelabs.com2015Vallejo, United States$293.9M43
Bioinformatics platform is provided for biomarkers and drug discovery.
depixus.com2012Paris, France$34.52M–
Single-molecule genetic and epigenetic sequencing solutions are provided.
genomics.com2014Oxford, United Kingdom$115.54M–
Genomic risk assessment and prevention platform is provided.
sevenbridges.com2009Cambridge, United States$113M112
Cloud-based platform to analyze, store, and act on genomic data.
Premium access

Detailed competitors of System Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of System Biosciences

The website of System Biosciences (systembio.com) receives about 23.8K visits a month.

  • Monthly visits
    23.8K

    ▲ 3.4% vs previous month

Similar websites

Websites whose visitors overlap most with System Biosciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
addgene.org
addgene.org
100%
–#84,256–
genecopoeia.com
99%
17.2K#1,512,108View details
herabiolabs.com
88%
––View details
biocat.com
88%
37.9K#866,969View details
abmgood.com
81%
680.7K#461,598View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for System Biosciences

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to System Biosciences

10 companies that operate in the same segment as System Biosciences (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about System Biosciences

System Biosciences was founded in 2009.

System Biosciences is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.

System Biosciences was founded in 2009 and is headquartered in Palo Alto, United States. Biotechnology tools for genomic and proteomic research are developed and supplied, including solutions for lentiviral gene delivery, knockdown processes, high-throughput RNAi screening, and products related to stem cell and microRNA studies. Expertise in exosome analysis is also maintained, supporting applications in diagnostics and precision medicine within the life sciences sector.

System Biosciences's top competitors include Helix, Benchling and BioAge Labs.

System Biosciences has 2 investors. Key investors include HHS, and Military Health.

System Biosciences operates through Asbi Production Cz S.R.O..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available